Skip to content

   Pharma Publications

Neuropsychopharmacology
  • IN MEMORIAM: Floyd E. Bloom, M.D
    Published on 2025-03-04
    4 months ago
  • Persistent brain network signatures in psychosis: implications for diagnosis, prognosis, and treatment
    Published on 2025-03-04
    4 months ago
  • Central Executive Network drives delta-9-tetrahydrocannabinol (THC)-induced nonlinear changes in large-scale functional connectivity in adolescent nonhuman primates
    Published on 2025-02-27
    4 months ago
  • A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse
    Published on 2025-02-27
    4 months ago
  • Pharmacological reduction of reverse-translated hippocampal hyperactivity in mouse: relevance for psychosis
    Published on 2025-02-26
    4 months ago
  • The crosstalk between CREB and PER2 mediates the transition between mania- and depression-like behavior
    Published on 2025-02-26
    4 months ago
  • Connectome-based predictive modeling of early and chronic psychosis symptoms
    Published on 2025-02-26
    4 months ago
« Previous 1 … 11 12 13 14 15 … 143 Next »
Journal of Psychopharmacology
  • Nighttime safety of daridorexant: Evaluation of responsiveness to an external noise stimulus, postural stability, walking, and cognitive function
    Published on 2024-12-06
    7 months ago
  • Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study
    Published on 2024-11-30
    7 months ago
  • Psychedelic risks and benefits: A cross-sectional survey study
    Published on 2024-11-29
    7 months ago
  • Exploring the effects of erythropoietin treatment on cortical thickness and hippocampal volume in patients with mood disorders undergoing electroconvulsive therapy: A randomized, placebo-controlled trial
    Published on 2024-11-29
    7 months ago
  • Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study
    Published on 2024-11-29
    7 months ago
  • Repurposing of erythropoietin as a neuroprotective agent against methotrexate-induced neurotoxicity in rats
    Published on 2024-11-13
    8 months ago
  • Promising strategies for the prevention of alcohol-related brain damage through optimised management of acute alcohol withdrawal: A focussed literature review
    Published on 2024-11-12
    8 months ago
« Previous 1 … 11 12 13 14 15 … 123 Next »
European Neuropsychopharmacology
  • Rare Genetic variation in schizophrenia: Are the most obvious ‘druggable pathways’ hiding in plain sight?
    Published on 2024-11-29
    7 months ago
  • Valproate’s impact on future generations — A call for stricter guidelines for maternal and paternal use
    Published on 2024-11-29
    7 months ago
  • Mitochondrial DNA copy number is significantly increased in bipolar disorder patients and is correlated with long-term lithium treatment
    Published on 2024-11-29
    7 months ago
  • Risk of mortality and complications in patients with severe mental illness and co-occurring diabetes mellitus: A systematic review and meta-analysis
    Published on 2024-11-29
    7 months ago
  • Clinical sleep staging for insomnia disorder
    Published on 2024-11-29
    7 months ago
  • Cannabis use and psychosis: evidence and new clinical features of a new epidemic
    Published on 2024-11-29
    7 months ago
  • Optimizing differential diagnostics and identifying transdiagnostic treatment targets using virtual reality
    Published on 2024-11-29
    7 months ago
« Previous 1 … 11 12 13 14 15 … 144 Next »

   Pharma Pub